Lv1
10 积分 2026-01-11 加入
Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer
17天前
已完结
Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1
17天前
已关闭
An anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) and chemotherapy for RAS/BRAF wild-type metastatic colorectal cancer: A phase Ib study
17天前
已完结
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial
17天前
已完结
Electroacupuncture combined with fruquintinib and sintilimab in microsatellite-stable metastatic colorectal cancer: A phase II study
17天前
已完结
The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy
17天前
已完结
Colorectal cancer immunotherapy-Recent progress and future directions
17天前
已完结
Mismatch repair deficiency/microsatellite instability (dMMR/MSI-H) in rectal cancer patients treated with standard neoadjuvant therapy: a systematic review and meta-analysis
1个月前
已完结
Novel Immunological Approaches in the Treatment of Locally Advanced Rectal Cancer
1个月前
已完结
Expert consensus on neoadjuvant therapy with short-course radiotherapy followed by chemotherapy combined with immunotherapy for patients with mismatch repair-proficient/microsatellite stable locally advanced rectal cancer (2025 edition)
1个月前
已完结
皖公网安备34019202002308
